Evidence map›Paper›PMID 33556194›Full record

ArticleClinical genetics2021

SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma.

Yuepei Liang, Yang Wang, Wenjing Wang, Juan Zhao, Mian Xu, Min Zheng

Open access · hybridAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yuepei LiangDepartment of Thoracic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
Yang WangDepartment of Thoracic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
Wenjing WangOrigiMed, Shanghai, China.
Juan ZhaoOrigiMed, Shanghai, China.
Mian XuOrigiMed, Shanghai, China.
Min ZhengDepartment of Thoracic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.ORCID 0000-0001-7381-111X
Guilin Medical University · CNUnimed Medical Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene FusionAdenocarcinoma of LungAnaplastic Lymphoma KinaseAntineoplastic AgentsEnzyme InhibitorsHigh-Throughput Nucleotide SequencingHumansLung NeoplasmsMaleMiddle AgedSphingomyelin PhosphodiesteraseAnaplastic Lymphoma KinaseAntineoplastic AgentsEnzyme InhibitorsSMPD3 protein, humanSphingomyelin Phosphodiesterase

Identifiers

PMID33556194
PMCPMC7898813
OpenAlexW3127096216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.